| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 07/04/2002 | US20020086414 Novel ctla4/cd28 ligands and uses therefor |
| 07/04/2002 | US20020086305 Human c-Maf compositions and methods of use thereof |
| 07/04/2002 | US20020086020 Method for improving the half-life of soluble viral receptors on mucosal membranes |
| 07/04/2002 | US20020085980 Oral care product comprising a mutan binding domain |
| 07/04/2002 | CA2432716A1 Process for producing recombinant protein and fused protein |
| 07/03/2002 | EP1218509A2 Fibroblast growth factor-like polypeptides |
| 07/03/2002 | EP1218504A2 Gl50 molecules and uses therefor |
| 07/03/2002 | EP1218501A1 Creation of variable length and sequence linker regions for dual-domain or multi-domain molecules |
| 07/03/2002 | EP1218414A2 Polypeptides for detection and elimination of ca19-9 antigen positive cells |
| 07/03/2002 | EP1218409A2 Factor-h related protein 5 (fhr-5) and antibodies thereto |
| 07/03/2002 | EP1218393A1 Cell targeting compositions and methods of using the same |
| 07/03/2002 | EP1218036A1 Cell based assay |
| 07/03/2002 | EP0892854B1 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 07/03/2002 | CN1357049A Receptor based antagonists and mehtods of making and using |
| 07/03/2002 | CN1357041A Head trauma induced cytoplasmatic calcium binding protein |
| 07/03/2002 | CN1357005A Process for partitioning of proteins |
| 07/03/2002 | CN1356341A Anti-idiotype microantibody and its preparing process and application |
| 07/02/2002 | US6414129 Cells containing expression vectors; diagnosis; immunomodulator detection; genetic engineering |
| 07/02/2002 | US6414117 Compositions and methods for the treatment and diagnosis of immune disorders |
| 07/02/2002 | US6413934 Biotin binding zones |
| 07/02/2002 | US6413932 Tek antagonists comprising soluble tek extracellular binding domain |
| 07/02/2002 | US6413770 NL4 tie ligand homologue nucleic acid |
| 07/02/2002 | US6413735 Method of screening for a modulator of angiogenesis |
| 07/02/2002 | US6413550 Proteinoid carriers and methods for preparation and use thereof |
| 07/02/2002 | CA2133203C Hybrid human/porcine factor viii |
| 07/02/2002 | CA2083172C Protein d - an igd-binding protein of haemophilus influenzae |
| 07/02/2002 | CA2050749C Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations |
| 06/27/2002 | WO2002050289A1 Methods for the production of multimeric proteins, and related compositions |
| 06/27/2002 | WO2002050287A2 Multifunctional protease inhibitors and their use in treatment of disease |
| 06/27/2002 | WO2002050250A2 Signal-1/signal-2 bifunctional peptide inhibitors |
| 06/27/2002 | WO2002050107A2 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/27/2002 | WO2002050097A2 Anti-allergic complex molecules |
| 06/27/2002 | WO2002020822A3 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 06/27/2002 | WO2002016548A3 Novel g protein-coupled receptor |
| 06/27/2002 | WO2002016415A3 Identification of a cam-kinase ii inhibitor |
| 06/27/2002 | WO2002012543A3 Two coloured fluorimetric protease assay |
| 06/27/2002 | WO2002005844A3 Protein complex serving as a vehicle for orally administerable medicaments |
| 06/27/2002 | WO2001081426A3 Rgd (arg-gly-asp) coupled to (neuro)peptides |
| 06/27/2002 | WO2001073025A3 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 06/27/2002 | WO2001038358A9 Hbv/hcv virus-like particle |
| 06/27/2002 | WO2001014536A3 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 06/27/2002 | US20020081690 Hybrid enzyme and use thereof |
| 06/27/2002 | US20020081682 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of bacterial infections |
| 06/27/2002 | US20020081664 Expression and export of interferon-alpha proteins as Fc fusion proteins |
| 06/27/2002 | US20020081307 Verotoxin b subunit for immunization |
| 06/27/2002 | US20020081298 An immunoglobulin or portion thereof linked to a T cell receptor agonist derived from an antigen responsible for an autoimmune disease, capable of undergoing Fc receptor medited ukptake by antigen presenting cells |
| 06/27/2002 | US20020081295 Virus-like particles for the induction of autoantibodies |
| 06/27/2002 | CA2789252A1 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/27/2002 | CA2432879A1 Anti-allergic complex molecules |
| 06/27/2002 | CA2432767A1 Signal-1/signal-2 bifunctional peptide inhibitors |
| 06/27/2002 | CA2432315A1 Methods for the production of multimeric proteins, and related compositions |
| 06/27/2002 | CA2430973A1 Multifunctional protease inhibitors and their use in treatment of disease |
| 06/26/2002 | EP1216055A2 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 06/26/2002 | CN1355844A Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 06/26/2002 | CN1355690A Method for improving half-life of soluble viral-specific ligands on mucosal membranes |
| 06/25/2002 | US6410696 Cyclosporin immunoassay |
| 06/25/2002 | US6410690 Therapeutic compounds comprised of anti-Fc receptor antibodies |
| 06/25/2002 | US6410507 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 06/25/2002 | US6410261 CIITA-interacting proteins and methods of use therefor |
| 06/25/2002 | US6410030 Polypeptide used as immunogenic element carried by peptide sequence between amino acid residues 130 and 230 of sequence of g protein of human respiratory syncytial virus of subgroups a and b, or of bovine respiratory syncytial virus |
| 06/25/2002 | US6410014 Administering protein-tyrosine kinase chimeras capable of directing cytotoxic t lymphocytes to specifically recognize and lyse target cells |
| 06/25/2002 | CA2123612C Hybrid protein between cs from plasmodium and h bsag |
| 06/25/2002 | CA2036814C Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof |
| 06/20/2002 | WO2002048359A1 Magnetic particle membrane-specific protein |
| 06/20/2002 | WO2002048358A2 Regulation of human chemokine-like receptor |
| 06/20/2002 | WO2002048195A2 Engineered stimulus-responsive switches |
| 06/20/2002 | WO2002048194A1 Fusion protein having the enhanced in vivo activity of erythropoietin |
| 06/20/2002 | WO2002048189A2 Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
| 06/20/2002 | WO2002047727A1 Therapeutic agent comprising a b-subunit of a protein toxin |
| 06/20/2002 | WO2002047534A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/20/2002 | WO2002016436A3 ANTIBODIES TO HUMAN IL-1$g(b) |
| 06/20/2002 | WO2001090152A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/20/2002 | WO2001083524A3 Rna metabolism proteins |
| 06/20/2002 | WO2001081417A3 Use of taci as an anti-tumor agent |
| 06/20/2002 | WO2001073086A3 Method for genetically modifying a plant |
| 06/20/2002 | WO2001051633A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/20/2002 | WO2001036448A8 Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions |
| 06/20/2002 | WO2000075333A9 Streptavidin expressed gene fusions and methods of use thereof |
| 06/20/2002 | US20020077460 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 06/20/2002 | US20020077457 Nucleotide sequences coding binding protein for use as diagnostic tools in genetic engineering |
| 06/20/2002 | US20020077294 Method of treating blood disorders |
| 06/20/2002 | US20020077288 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 06/20/2002 | US20020077283 Blocking interaction of caveolin with a protein in vivo by administering peptide which comprises caveolin scaffolding domain |
| 06/20/2002 | US20020076761 Polypeptides for use in human therapeutics and diagnostics |
| 06/20/2002 | US20020076755 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 06/20/2002 | US20020076416 Chimeric peptide immunogens |
| 06/20/2002 | CA2434915A1 Therapeutic agent comprising a b-subunit of a protein toxin |
| 06/20/2002 | CA2430953A1 Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
| 06/19/2002 | EP1214453A1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 06/19/2002 | EP1214413A1 Human paralogue of a head trauma induced cytoplasmatic calcium binding protein |
| 06/19/2002 | EP1214344A1 Dipeptidyl peptidases |
| 06/19/2002 | EP1214343A2 T2r taste receptor family |
| 06/19/2002 | EP1214340A2 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 06/19/2002 | EP1214097A1 Nucleic acids encoding polyepitope polypeptides |
| 06/19/2002 | CN1354791A Compositions for treatment and diagnosis of breast cancer and methods for their use |
| 06/19/2002 | CN1354755A Nucleotide and protein sequence of Nogo genes and methods based thereon |
| 06/19/2002 | CN1354675A Adjuvant combination formulations |
| 06/19/2002 | CN1354253A Dilutus culex trypsase gene |
| 06/18/2002 | US6407216 Vertebrate smoothened antibodies |
| 06/18/2002 | US6407213 Method for making humanized antibodies |